Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.

Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X.

Nat Nanotechnol. 2020 Jan 17. doi: 10.1038/s41565-020-0635-3. [Epub ahead of print]

PMID:
31953520
2.

Optimizing the interfacial electron transfer capability of single layer graphene by thermal annealing.

Liu X, Sartin MM, Liu Y, Tian ZQ, Zhan D.

Chem Commun (Camb). 2019 Dec 19;56(2):253-256. doi: 10.1039/c9cc08150j.

PMID:
31803874
3.

Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B.

Liu Y, Li H, Yan X, Wei J.

J Viral Hepat. 2019 Jul;26 Suppl 1:69-76. doi: 10.1111/jvh.13154.

PMID:
31380585
4.

Facile synthesis of phosphorus-doped carbon under tuned temperature with high lithium and sodium anodic performances.

Zhao Q, Meng Y, Yang L, He X, He B, Liu Y, Xiao D.

J Colloid Interface Sci. 2019 Sep 1;551:61-71. doi: 10.1016/j.jcis.2019.05.021. Epub 2019 May 6.

PMID:
31075634
5.

Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis.

Lin B, Ma Y, Wu S, Liu Y, Liu L, Wu L.

OMICS. 2019 Apr;23(4):181-189. doi: 10.1089/omi.2019.0035. Epub 2019 Mar 30.

PMID:
30932742
6.

High-throughput acoustofluidic fabrication of tumor spheroids.

Chen B, Wu Y, Ao Z, Cai H, Nunez A, Liu Y, Foley J, Nephew K, Lu X, Guo F.

Lab Chip. 2019 May 14;19(10):1755-1763. doi: 10.1039/c9lc00135b.

PMID:
30918934
7.

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.

Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X.

Nat Nanotechnol. 2019 May;14(5):496. doi: 10.1038/s41565-019-0417-y.

PMID:
30837690
8.

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.

Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X.

Nat Nanotechnol. 2019 Apr;14(4):388-397. doi: 10.1038/s41565-019-0381-6. Epub 2019 Feb 25. Erratum in: Nat Nanotechnol. 2019 Mar 5;:. Nat Nanotechnol. 2020 Jan 17;:.

9.

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.

Liu Y, Xu J, Choi HH, Han C, Fang Y, Li Y, Van der Jeught K, Xu H, Zhang L, Frieden M, Wang L, Eyvani H, Sun Y, Zhao G, Zhang Y, Liu S, Wan J, Huang C, Ji G, Lu X, He X, Zhang X.

Nat Commun. 2018 Nov 9;9(1):4718. doi: 10.1038/s41467-018-07264-0.

10.

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.

Li Y, Liu Y, Xu H, Jiang G, Van der Jeught K, Fang Y, Zhou Z, Zhang L, Frieden M, Wang L, Luo Z, Radovich M, Schneider BP, Deng Y, Liu Y, Huang K, He B, Wang J, He X, Zhang X, Ji G, Lu X.

Nat Commun. 2018 Oct 22;9(1):4394. doi: 10.1038/s41467-018-06811-z.

11.

Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.

Liu Y, Xu H, Van der Jeught K, Li Y, Liu S, Zhang L, Fang Y, Zhang X, Radovich M, Schneider BP, He X, Huang C, Zhang C, Wan J, Ji G, Lu X.

J Clin Invest. 2018 Jul 2;128(7):2951-2965. doi: 10.1172/JCI98727. Epub 2018 Jun 4.

12.

Sustained Responses in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue Drug-resistance after Peg-interferon Alfa-2a Add-on Treatment: A Long-term Cohort Study.

Liu Y, Li W, Jia T, Peng D, Li H, Li X, Lv S.

J Clin Transl Hepatol. 2018 Mar 28;6(1):18-24. doi: 10.14218/JCTH.2017.00041. Epub 2018 Jan 15.

13.

Transcriptomic and Metabolomic Studies Disclose Key Metabolism Pathways Contributing to Well-maintained Photosynthesis under the Drought and the Consequent Drought-Tolerance in Rice.

Ma X, Xia H, Liu Y, Wei H, Zheng X, Song C, Chen L, Liu H, Luo L.

Front Plant Sci. 2016 Dec 21;7:1886. doi: 10.3389/fpls.2016.01886. eCollection 2016.

14.

Amplification of USP13 drives ovarian cancer metabolism.

Han C, Yang L, Choi HH, Baddour J, Achreja A, Liu Y, Li Y, Li J, Wan G, Huang C, Ji G, Zhang X, Nagrath D, Lu X.

Nat Commun. 2016 Nov 28;7:13525. doi: 10.1038/ncomms13525.

15.

Genetic determination of the enhanced drought resistance of rice maintainer HuHan2B by pedigree breeding.

Wei H, Feng F, Lou Q, Xia H, Ma X, Liu Y, Xu K, Yu X, Mei H, Luo L.

Sci Rep. 2016 Nov 17;6:37302. doi: 10.1038/srep37302.

16.

A novel gene OsAHL1 improves both drought avoidance and drought tolerance in rice.

Zhou L, Liu Z, Liu Y, Kong D, Li T, Yu S, Mei H, Xu X, Liu H, Chen L, Luo L.

Sci Rep. 2016 Jul 25;6:30264. doi: 10.1038/srep30264.

17.

Relationship of Productivity to Species Richness in the Xinjiang Temperate Grassland.

Liu L, Cheng J, Liu Y, Sheng J.

PLoS One. 2016 Apr 21;11(4):e0154026. doi: 10.1371/journal.pone.0154026. eCollection 2016.

18.

Analysis of long-term follow-up and examination of pathological liver tissue in chronic hepatitis E.

Liu L, Liu Y, Du Y, Liu C, Li W, Li H, Jia T, Chang L.

Dig Liver Dis. 2016 Jun;48(6):684-6. doi: 10.1016/j.dld.2016.02.016. Epub 2016 Mar 22.

PMID:
27038702
19.

Regulators in the DNA damage response.

Liu Y, Li Y, Lu X.

Arch Biochem Biophys. 2016 Mar 15;594:18-25. doi: 10.1016/j.abb.2016.02.018. Epub 2016 Feb 13. Review.

PMID:
26882840
20.

A new way to target p53-defective colorectal cancer.

Liu Y, Wang L, Lu X.

Future Oncol. 2015;11(23):3101-4. doi: 10.2217/fon.15.223. Epub 2015 Nov 9. No abstract available.

Supplemental Content

Loading ...
Support Center